Close Menu

NEW YORK (GenomeWeb) – The Jackson Laboratory announced last week that it has won a $1.4 million grant from the US Department of Defense (DoD) to develop a new method for classifying triple-negative breast cancer (TNBC) tumors, which could lead to the development of better diagnostics and precision treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.